# Track 013 dependency review — Quality, validation, gap mapping and equity assurance

**Review date:** 2026-07-27  
**Decision:** Blocked pending Tracks 003, 005, 007, 010, 011 and 012

## Findings

- Tracks 003, 005, 010, 011 and 012 are blocked; Track 007 remains in review.
- No Track 013 assurance framework, gap map, equity assessment or independent reproduction has been implemented.
- Scientific, patient/community, data-governance and programme gates remain required.

Repository-owned assurance work is now documented in
`docs/quality-validation-013-reference.md`, covering executable evidence-quality,
transportability, quality-disposition, GATHER and capability-gap contracts. The
controls remain deliberately non-empirical and do not assert equity or
calibration sufficiency.

### Review rerun — 2026-07-29

Repository review result: **Pass with dependency and assurance gates**. The
assurance primitives and gap-map boundaries are internally consistent, and the
full validation gate passes. Track 013 remains blocked pending prerequisite
demonstrators, independent reproduction, scientific assurance and
patient/community, data-governance and programme review.

### Repository-owned implementation slice — 2026-08-01

The validation-type, calibration-rule, model-criticism and evidence-maturity
definitions are now recorded in `docs/quality-validation-013-protocol.md`.
They are explicitly non-empirical and fail-closed: missing independent evidence
is `not_assessed`, and no language permits representativeness, endorsement or
global validity without the corresponding external disposition.

## Disposition

Keep Track 013 **blocked**. Do not assess, triangulate or approve atlas-beta outputs until the prerequisite demonstrators and burden-engine contracts are complete.

### Review rerun — 2026-08-01

The repository-owned assurance slice was rechecked against the specification
and stable-v1 controls. The evidence-quality, transportability,
quality-disposition, GATHER, maturity-language and deterministic gap-map
contracts are present, schema-validated, and fail closed when independent or
equity evidence is absent. The protocol explicitly distinguishes synthetic
reference evidence from empirical validation and does not claim global
representativeness or community endorsement.

No repository-owned defect was found in this slice, and no controlled or
participant-level data were added. The unchecked plan items are substantive
release gates, not documentation omissions: rendered empirical coverage and
controlled-data asks, underserved/Indigenous governance assessment,
demonstrator triangulation, uncertainty decomposition, independent
reproduction, patient/community review, and scientific disposition remain
outstanding. Prerequisite tracks 003, 005, 007, 010, 011 and 012 are not all
complete. Track 013 therefore remains **blocked** and is not archive-eligible.
